Macroautophagy Is Regulated by the UPR–Mediator CHOP and Accentuates the Phenotype of SBMA Mice
Altered protein homeostasis underlies degenerative diseases triggered by misfolded proteins, including spinal and bulbar muscular atrophy (SBMA), a neuromuscular disorder caused by a CAG/glutamine expansion in the androgen receptor. Here we show that the unfolded protein response (UPR), an ER protein quality control pathway, is induced in skeletal muscle from SBMA patients, AR113Q knock-in male mice, and surgically denervated wild-type mice. To probe the consequence of UPR induction, we deleted CHOP (C/EBP homologous protein), a transcription factor induced following ER stress. CHOP deficiency accentuated atrophy in both AR113Q and surgically denervated muscle through activation of macroautophagy, a lysosomal protein quality control pathway. Conversely, impaired autophagy due to Beclin-1 haploinsufficiency decreased muscle wasting and extended lifespan of AR113Q males, producing a significant and unexpected amelioration of the disease phenotype. Our findings highlight critical cross-talk between the UPR and macroautophagy, and they indicate that autophagy activation accentuates aspects of the SBMA phenotype.
Vyšlo v časopise:
Macroautophagy Is Regulated by the UPR–Mediator CHOP and Accentuates the Phenotype of SBMA Mice. PLoS Genet 7(10): e32767. doi:10.1371/journal.pgen.1002321
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002321
Souhrn
Altered protein homeostasis underlies degenerative diseases triggered by misfolded proteins, including spinal and bulbar muscular atrophy (SBMA), a neuromuscular disorder caused by a CAG/glutamine expansion in the androgen receptor. Here we show that the unfolded protein response (UPR), an ER protein quality control pathway, is induced in skeletal muscle from SBMA patients, AR113Q knock-in male mice, and surgically denervated wild-type mice. To probe the consequence of UPR induction, we deleted CHOP (C/EBP homologous protein), a transcription factor induced following ER stress. CHOP deficiency accentuated atrophy in both AR113Q and surgically denervated muscle through activation of macroautophagy, a lysosomal protein quality control pathway. Conversely, impaired autophagy due to Beclin-1 haploinsufficiency decreased muscle wasting and extended lifespan of AR113Q males, producing a significant and unexpected amelioration of the disease phenotype. Our findings highlight critical cross-talk between the UPR and macroautophagy, and they indicate that autophagy activation accentuates aspects of the SBMA phenotype.
Zdroje
1. OrrHTZoghbiHY 2007 Trinucleotide repeat disorders. Annu Rev Neurosci 30 575 621
2. ZoghbiHYOrrHT 2000 Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23 217 247
3. LiebermanAPFischbeckKH 2000 Triplet repeat expansion in neuromuscular disease. Muscle Nerve 23 843 850
4. KatsunoMAdachiHWazaMBannoHSuzukiK 2006 Pathogenesis, animal models and therapeutics in Spinal and bulbar muscular atrophy (SBMA). Exp Neurol
5. SperfeldADKaritzkyJBrummerDSchreiberHHausslerJ 2002 X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol 59 1921 1926
6. KennedyWRAlterMSungJH 1968 Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 18 671 680
7. SobueGHashizumeYMukaiEHirayamaMMitsumaT 1989 X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 112 Pt 1 209 232
8. Chevalier-LarsenESO'BrienCJWangHJenkinsSCHolderL 2004 Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci 24 4778 4786
9. KatsunoMAdachiHKumeALiMNakagomiY 2002 Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35 843 854
10. BannoHKatsunoMSuzukiKTakeuchiYKawashimaM 2009 Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol 65 140 150
11. KatsunoMBannoHSuzukiKTakeuchiYKawashimaM 2010 Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol
12. Fernandez-RhodesLEKokkinisADWhiteMJWattsCAAuhS 2011 Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol 10 140 147
13. AlbertelliMASchellerABrogleyMRobinsDM 2006 Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol 20 1248 1260
14. YuZDadgarNAlbertelliMGruisKJordanC 2006 Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest 116 2663 2672
15. YuZDadgarNAlbertelliMSchellerAAlbinRL 2006 Abnormalities of Germ Cell Maturation and Sertoli Cell Cytoskeleton in Androgen Receptor 113 CAG Knock-In Mice Reveal Toxic Effects of the Mutant Protein. Am J Pathol 168 195 204
16. MonksDAJohansenJAMoKRaoPEaglesonB 2007 Overexpressioin of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci U S A
17. PalazzoloIStackCKongLMusaroAAdachiH 2009 Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 63 316 328
18. ChamberlainNLDriverEDMiesfeldRL 1994 The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22 3181 3186
19. IrvineRAMaHYuMCRossRKStallcupMR 2000 Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet 9 267 274
20. Kazemi-EsfarjaniPTrifiroMAPinskyL 1995 Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet 4 523 527
21. MhatreANTrifiroMAKaufmanMKazemi-EsfarjaniPFiglewiczD 1993 Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat Genet 5 184 188
22. LiebermanAPHarmisonGStrandADOlsonJMFischbeckKH 2002 Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum Mol Genet 11 1967 1976
23. McCampbellATaylorJPTayeAARobitschekJLiM 2000 CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet 9 2197 2202
24. YuZWangAMRobinsDMLiebermanAP 2009 Altered RNA splicing contributes to skeletal muscle pathology in Kennedy disease knock-in mice. Dis Model Mech 2 500 507
25. KatsunoMAdachiHMinamiyamaMWazaMTokuiK 2006 Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. J Neurosci 26 12106 12117
26. PiccioniFPintonPSimeoniSPozziPFascioU 2002 Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes. Faseb J 16 1418 1420
27. SzebenyiGMorfiniGABabcockAGouldMSelkoeK 2003 Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40 41 52
28. RanganathanSHarmisonGGMeyertholenKPennutoMBurnettBG 2009 Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum Mol Genet 18 27 42
29. ThomasMHarrellJMMorishimaYPengHMPrattWB 2006 Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction. Hum Mol Genet 15 1876 1883
30. WazaMAdachiHKatsunoMMinamiyamaMSangC 2005 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat Med 11 1088 1095
31. AdachiHWazaMTokuiKKatsunoMMinamiyamaM 2007 CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. J Neurosci 27 5115 5126
32. MorishimaYWangAMYuZPrattWBOsawaY 2008 CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins. Hum Mol Genet 17 3942 3952
33. WangAMMorishimaYClappKMPengHMPrattWB 2010 Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation. J Biol Chem 285 15714 15723
34. RonD 2002 Translational control in the endoplasmic reticulum stress response. J Clin Invest 110 1383 1388
35. RonDWalterP 2007 Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8 519 529
36. ThomasMYuZDadgarNVaramballySYuJ 2005 The unfolded protein response modulates toxicity of the expanded glutamine androgen receptor. J Biol Chem 280 21264 21271
37. ZinsznerHKurodaMWangXBatchvarovaNLightfootRT 1998 CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12 982 995
38. SouthwoodCMGarbernJJiangWGowA 2002 The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36 585 596
39. PennutoMTinelliEMalagutiMDel CarroUD'AntonioM 2008 Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron 57 393 405
40. KostrominovaTYDowDEDennisRGMillerRAFaulknerJA 2005 Comparison of gene expression of 2-mo denervated, 2-mo stimulated-denervated, and control rat skeletal muscles. Physiol Genomics 22 227 243
41. GlassDJ 2003 Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 5 87 90
42. MammucariCMilanGRomanelloVMasieroERudolfR 2007 FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6 458 471
43. MontieHLChoMSHolderLLiuYTsvetkovAS 2009 Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet 18 1937 1950
44. HetzCThielenPMatusSNassifMCourtF 2009 XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev 23 2294 2306
45. KourokuYFujitaETanidaIUenoTIsoaiA 2007 ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ 14 230 239
46. OgataMHinoSSaitoAMorikawaKKondoS 2006 Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 26 9220 9231
47. YueZJinSYangCLevineAJHeintzN 2003 Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 100 15077 15082
48. ZhongYWangQJLiXYanYBackerJM 2009 Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex. Nat Cell Biol 11 468 476
49. QuXYuJBhagatGFuruyaNHibshooshH 2003 Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112 1809 1820
50. KourokuYFujitaEJimboAKikuchiTYamagataT 2002 Polyglutamine aggregates stimulate ER stress signals and caspase-12 activation. Hum Mol Genet 11 1505 1515
51. NishitohHMatsuzawaATobiumeKSaegusaKTakedaK 2002 ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 16 1345 1355
52. CarnemollaAFossaleEAgostoniEMichelazziSCalligarisR 2009 Rrs1 is involved in endoplasmic reticulum stress response in Huntington disease. J Biol Chem 284 18167 18173
53. UranoFWangXBertolottiAZhangYChungP 2000 Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287 664 666
54. PandeyUBNieZBatleviYMcCrayBARitsonGP 2007 HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447 859 863
55. RavikumarBVacherCBergerZDaviesJELuoS 2004 Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36 585 595
56. WilliamsASarkarSCuddonPTtofiEKSaikiS 2008 Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat Chem Biol 4 295 305
57. RennaMJimenez-SanchezMSarkarSRubinszteinDC 2010 Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J Biol Chem 285 11061 11067
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2011 Číslo 10
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- The Glycobiome Reveals Mechanisms of Pentose and Hexose Co-Utilization in Bacteria
- Global Mapping of Cell Type–Specific Open Chromatin by FAIRE-seq Reveals the Regulatory Role of the NFI Family in Adipocyte Differentiation
- Genetic Determinants of Serum Testosterone Concentrations in Men
- MicroRNA Expression and Regulation in Human, Chimpanzee, and Macaque Brains